Skip to content

HIV-positive syphilis patients harder to treat for neurological complications

Hetero withdraws 6 HIV drugs from WHO prequalification list

Children may benefit from a higher dose of nevirapine than recommended by manufacturer

Co-trimoxazole reduces risk of death for children in Zambia, should be given to all children with HIV symptoms, say researchers

Atazanavir/ritonavir shows comparable efficacy to Kaletra at 96 weeks for PI-experienced patients

Rates of TB treatment interruption unaffected by HIV infection or HAART

AZT resistance suppression mutations can also reduce tenofovir resistance, test tube study shows (corrected)

Double boosted protease inhibitors generate interest at Glasgow conference

High resistance levels seen in treated Ugandans: cost of therapy blamed